BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1453 related articles for article (PubMed ID: 19597069)

  • 1. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
    Torn M; van der Meer FJ; Rosendaal FR
    Arch Intern Med; 2004 Mar; 164(6):668-73. PubMed ID: 15037497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.
    Pengo V; Barbero F; Banzato A; Garelli E; Noventa F; Biasiolo A; Zasso A; Dalla Volta S
    Thromb Haemost; 1997 May; 77(5):839-44. PubMed ID: 9184389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V; Legnani C; Noventa F; Palareti G;
    Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial.
    Torella M; Torella D; Chiodini P; Franciulli M; Romano G; De Santo L; De Feo M; Amarelli C; Sasso FC; Salvatore T; Ellison GM; Indolfi C; Cotrufo M; Nappi G
    Am Heart J; 2010 Jul; 160(1):171-8. PubMed ID: 20598989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed?
    Verheugt FW
    Thromb Haemost; 1999 Sep; 82 Suppl 1():130-5. PubMed ID: 10695504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
    Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
    J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal oral anticoagulant therapy in patients with mechanical heart valves.
    Cannegieter SC; Rosendaal FR; Wintzen AR; van der Meer FJ; Vandenbroucke JP; Briët E
    N Engl J Med; 1995 Jul; 333(1):11-7. PubMed ID: 7776988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
    Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
    Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thromboembolic and bleeding complications in patients treated with oral anticoagulant therapy after mechanical heart valve prostheses implantation].
    Kanaoka Y; Tanemoto K; Murakami T; Kuroki K
    Kyobu Geka; 2000 Aug; 53(9):754-8. PubMed ID: 10935402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of mechanical heart valve thrombosis through a clinical audit.
    Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R
    J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
    Pengo V; Cucchini U; Denas G; Davidson BL; Marzot F; Jose SP; Iliceto S
    Thromb Haemost; 2010 Feb; 103(2):442-9. PubMed ID: 20076843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
    Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major hemorrhagic and thromboembolic complications in patients with mechanical heart valves receiving oral anticoagulant therapy.
    Trzeciak P; Zembala M; Poloński L
    Heart Surg Forum; 2010 Apr; 13(2):E80-5. PubMed ID: 20444682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.